EP 0767792 A4 20021120 - VITRONECTIN RECEPTOR ANTAGONISTS
Title (en)
VITRONECTIN RECEPTOR ANTAGONISTS
Title (de)
VITRONECTIN-REZEPTOR ANTAGONISTEN
Title (fr)
ANTAGONISTES DU RECEPTEUR DE LA VITRONECTINE
Publication
Application
Priority
- US 9508306 W 19950629
- US 26769594 A 19940629
- US 42893395 A 19950425
Abstract (en)
[origin: WO9600730A1] Compounds are disclosed which are vitronectin receptor antagonists useful in the treatment of osteoporosis. These compounds comprise a fibrinogen receptor antagonist template linked to a heterocyclic moiety.
IPC 1-7
C07D 519/00; C07D 498/04; C07D 497/04; C07D 495/04; C07D 491/04; C07D 491/044; C07D 491/048; C07D 491/052; C07D 487/04; C07D 473/04; C07D 403/12
IPC 8 full level
A61K 31/415 (2006.01); A61K 31/4184 (2006.01); A61K 31/44 (2006.01); A61K 31/4427 (2006.01); A61K 31/443 (2006.01); A61K 31/445 (2006.01); A61K 31/454 (2006.01); A61K 31/47 (2006.01); A61K 31/495 (2006.01); A61K 31/496 (2006.01); A61K 31/55 (2006.01); A61K 31/551 (2006.01); A61P 9/10 (2006.01); A61P 19/10 (2006.01); A61P 29/00 (2006.01); A61P 35/00 (2006.01); A61P 43/00 (2006.01); C07D 223/16 (2006.01); C07D 233/56 (2006.01); C07D 233/64 (2006.01); C07D 235/14 (2006.01); C07D 235/20 (2006.01); C07D 243/14 (2006.01); C07D 401/06 (2006.01); C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 403/06 (2006.01); C07D 403/12 (2006.01); C07D 403/14 (2006.01); C07D 405/12 (2006.01); C07D 405/14 (2006.01); C07D 413/12 (2006.01); C07D 417/12 (2006.01); C07D 471/04 (2006.01); C07D 491/04 (2006.01); C07D 491/056 (2006.01)
CPC (source: EP)
A61P 9/10 (2017.12); A61P 19/10 (2017.12); A61P 29/00 (2017.12); A61P 35/00 (2017.12); A61P 43/00 (2017.12); C07D 223/16 (2013.01); C07D 235/14 (2013.01); C07D 243/14 (2013.01); C07D 401/06 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 403/12 (2013.01); C07D 403/14 (2013.01); C07D 413/12 (2013.01); C07D 417/12 (2013.01); C07D 471/04 (2013.01); C07D 491/04 (2013.01)
Citation (search report)
- [A] EP 0385850 A2 19900905 - UNION PHARMA SCIENT APPL [FR]
- [A] EP 0468470 A1 19920129 - THOMAE GMBH DR K [DE]
- [PA] WO 9415608 A1 19940721 - AGOURON PHARMA [US], et al
- [A] FELDING-HABERMANN B ET AL: "VITRONECTIN AND ITS RECEPTORS", CURRENT OPINION IN CELL BIOLOGY, CURRENT SCIENCE, LONDON, GB, vol. 5, 1993, pages 864 - 868, XP000885406, ISSN: 0955-0674
- [X] PASCAL, ROBERT A., JR. ET AL: "Reactions of 2-dichloromethylbenzimidazole with certain primary amines", J. HETEROCYCL. CHEM. ( 1978 ), 15(1), 141-4, XP001094591
- See references of WO 9600730A1
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9600730 A1 19960111; AU 3001095 A 19960125; AU 702661 B2 19990225; BR 9508178 A 19971118; CA 2193966 A1 19960111; CN 1156995 A 19970813; CZ 382496 A3 19971217; EP 0767792 A1 19970416; EP 0767792 A4 20021120; HU 9603525 D0 19970228; HU T76344 A 19970828; JP H10504808 A 19980512; MX 9700041 A 19970430; NO 965608 D0 19961227; NO 965608 L 19970227; NZ 290008 A 19980826; NZ 329656 A 20000128; NZ 329822 A 20000228; PL 318199 A1 19970526
DOCDB simple family (application)
US 9508306 W 19950629; AU 3001095 A 19950629; BR 9508178 A 19950629; CA 2193966 A 19950629; CN 95194853 A 19950629; CZ 382496 A 19950629; EP 95926152 A 19950629; HU 9603525 A 19950629; JP 50346296 A 19950629; MX 9700041 A 19950629; NO 965608 A 19961227; NZ 29000895 A 19950629; NZ 32965698 A 19980128; NZ 32982298 A 19980223; PL 31819995 A 19950629